Introduction
Throughout the history of the world, the ones who had confronted the bitterest face of poverty and war had always been the women. As known poverty and war affects human health either directly or indirectly, the effects of this condition on health and status of women in the society should not be ignored. This study intends to cast light on the effects of war and poverty on the reproductive health of women. For this purpose, the face of war affecting the women, the problem of immigration, inequalities in distribution of income based on gender and the effects of all these on the reproductive health of women will be addressed.
War and Women's Health
Famine, synonymous with war and poverty, is clearer for women; war means deep disadvantages such as full destruction, loss of future and uncertainty for women. Wars are conflicts that destroy families, societies and cultures that negatively affect the health of community and cause violation of human rights. According to the data of World Health Organization (WHO) and World Bank, in 2002 wars had been among the first ten reasons which killed the most and caused disabilities. Civil losses are at the rate of 90% within all losses (1) . War has many negative effects on human health. One of these is its effect of shortening the average human life. According to the data of WHO, the average human life is 68.1 years for males and 72.7 years for females. It is being thought that severe military conflicts in Africa shorten the expected lifetime for more than 2 years. In general, WHO had calculated that 269 thousand people had died in 1999 due to the effect of wars and that loss of 8.44 million healthy years of life had occurred (2, 3) . Wars negatively affect the provision of health services. Health institutions such as hospitals, laboratories and health centers are direct targets of war. Moreover, the wars cause the migration of qualified health employees, and thus the health services hitches. Assessments made indicate that the effect of destruction in the infrastructure of health continues for 5-10 years even after the finalization of conflicts (3) . Due to resource requirements in the restructuring investments after war, the share allocated to health has decreased (1).
Mortalities and Morbidities
The ones who are most affected from wars are women and children. While deaths depending on direct violence affect the male population, the indirect deaths kill children, women and elders more. In Iraq between 1990-1994, infant deaths had shown this reality in its more bare form with an increase of 600% (4). The war taking five years increases the child deaths under age of 5 by 13%. Also 47% of all the refugees in the world and 50% of asylum seekers and displaced people are women and girls and 44% refugees and asylum seekers are children under the age of 18 (5) . As the result of wars and armed conflicts, women are
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Herbal medicines have long been used for the treatment of female reproductive disorders as they contain pharmacologically active components showing promising effects in patients with (17) PCOS, diabetes, and cardiovascular diseases (18, 19) . Galega officinalis is a natural plant belonging to the Middle East (20) and southeastern part of Europe (21) . In the Medieval period, it was used as a therapy for diabetes (20, 22) . One of the main components of G. officinalis is alkaloid galegine possessing hypoglycemic properties in animal models (23) . Furthermore, it was shown that G. officinalis has a remarkable effect on body weight loss and insulin (24) . Therefore, for the treatment of diabetes, the use of this herb can open a new avenue by increasing the sensitivity of tissues to insulin and reducing the tissue damage (19) .
However, since PCOS results in damage to organs and tissues of the human body, such as the ovaries, the kernel goal of the study was to examine the effects of G. officinalis extract on the damage of ovarian tissue as well as biochemical factors altered as a result of PCOS.
Materials and Methods
In the present study, 32 adult female Wistar rats (weighing 200-250 g) were used. All rats were procured from Razi Institute, Mashhad, Iran. They were carefully kept in the animal house under standard conditions (temperature 22°C and 12 h/12 h light/dark cycle) and had free access to food and water.
Experimental Groups and Study Design Rats were randomly divided into 4 groups (n=8/group), as one control group and three experimental groups. 1: Healthy or control group (control). 2: PCOS control group (PCO), in which PCOS was induced by an intramuscular injection (IM) of 16 mg/kg estradiol valerate (Sigma, Germany) (a single dose) which was dissolved in 0.2 ml of sesame oil (25) . 3: PCOS group (PG200) was treated with the hydroalcoholic extract of G. officinalis (200 mg/kg/orally/ daily) for 2 weeks. 4: PCOS group (PG400) was treated with the hydroalcoholic extract of G. officinalis (400 mg/kg/orally/ daily) for 2 weeks.
The vaginal smear was examined daily and estrus cycle was confirmed in all rats. After the treatment period, all rats were anesthetized with ketamine/xylazine (5/1 mg/ kg) (19, 26) , then the blood samples were taken from the hearts of all rats and the serum was separated by centrifugation at 3500 g. The obtained sera were kept at -70°C until the further analysis
Preparation of Hydroalcoholic Extract of Galega officinalis
To prepare the extract of G. officinalis, half a kilogram of this plant was purchased from Dineh Company (Iran). For extraction, the plant was firstly dissolved in 2 liters of alcohol 50% and distilled water and then was kept for 48 hours at room temperature on a shaker (Thermo Fisher). Then, the solution was filtered and centrifuged for 5 minutes at 3000 rpm. At the end of this process, the resulting solution was poured into an open-top container and the solvent was evaporated. Finally, to achieve an appropriate concentration, the extract was dissolved in normal saline.
Measurement of Serum Glucose Level
At the commencement of this study, in samples which were obtained from the tip of the vein of rats' tail, the level of fasting blood sugar (FBS) was measured using a portable glucometer. Accordingly, at the end of the experiment period, the serum glucose level was analyzed using a commercial kit (Pars Azmun, Iran). The value was expressed as mg/dL.
Measurement of Serum Insulin Level
The measurement of serum insulin concentration was carried out by ELISA (enzyme-linked immunosorbent assay) using a commercial kit specified for rats (Mercodia, Sweden). Serum insulin levels were expressed as mIU/mL.
Measurement of the Serum Levels of Testosterone, Estrogen, FSH, LH, and Aromatase Serum hormone levels were quantified using ELISA kits for testosterone and estrogen (Demeditec, Germany). The absorbance was recorded at 405 nm for analyzing testosterone and estrogen. Correspondingly, the serum levels of aromatase, FSH, as well as LH were also determined using an ELISA kit (Cusabio, China).
Histological Study
The histological examinations were carried out based on previous experimental studies. The ovarian samples were immersed in the formalin 10% solution for 72 hours. After fixation, they were dehydrated and embedded in paraffin. Then they were cut into 5 microns thick sections to make tissue samples. They were deparaffinized, stained with hematoxylin-eosin (H&E), then, evaluated the sections of each ovarian tissue (n = 7) from the cortex of ovary to the medulla in a spiral and clockwise direction. In each of the ovarian slide, the number of primary Follicles, pre-antral, antral, cystic follicles and yellow body were enumerated. All sections were assessed by an optical microscope (NIKON) at a magnification of ×100 (27) (28) (29) .
Statistical Analysis The statistical analysis of the present study was carried out using SPSS software 19.0. All data were presented as mean ± standard error of mean (SEM) and were compared using one-way ANOVA and Tukey post hoc test. P < 0.05 was considered statistically significant.
Results

Serum Level of FBS
In PCOS group, the serum level of FBS was significantly higher compared to control group (P < 0.05) (Figure 1) . In treated groups received 200 and 400 mg/kg of G. officinalis extract, the serum level of glucose was significantly lower in comparison to the group affected by PCOS (P < 0.05).
Serum Level of Insulin In PCOS group, the serum level of insulin was statistically increased in comparison to control group (P < 0.05) (Figure 2 ). However, it was significantly decreased in treated groups, PG 200 and PG 400, in comparison to the group affected by PCOS (P < 0.05).
The Serum Levels of Testosterone, Estrogen, LH, FSH and Aromatase The serum levels of testosterone, estrogen, FSH, and LH were shown in Table 1 . According to Table 1 , the serum testosterone level was significantly higher in PCOS group compared to control group (P < 0.05). Moreover, in both treated groups (PG200 and PG400) the serum levels of testosterone were significantly reduced in comparison to PCOS group (P < 0.05). Moreover, there was a significant difference in levels of serum estrogen between PCOS and control groups (P < 0.05). Serum estrogen level was increased in treated groups when compared to PCOS group (P < 0.05). In PCOS group, there was a significant increase in serum levels of LH and FSH compared to control group (P < 0.05). Conversely, in both treated groups, the serum levels of gonadotropin hormones (LH and FSH) were significantly decreased in comparison with PCOS group (P < 0.05). Likewise, in PCOS group, the serum level of aromatase was significantly decreased compared to control group (P < 0.05) (Figure 3) . In both groups treated with G. officinalis, the serum aromatase level was significantly increased compared to PCOS group (P < 0.05).
The Number of Follicles The number of pre-antral follicles, antral follicles, cystic follicles and yellow bodies is presented in Table 2 and Figure 4 shows the light microscope micrograph of ovaries. However, the number of primary follicles was significantly declined in PCOS group in comparison to control group (P < 0.05). Moreover, a significant difference was observed between PCOS group and two treated groups (P < 0.05). In PCOS group, the number of pre-antral follicles was significantly declined compared to control group (P < 0.05), while the number of pre-antral follicles was significantly higher in both treated groups compared to PCOS group (P < 0.05). On the other hand, in PCOS group, enumerating the antral follicles showed a significant decrease in comparison to control group (P < 0.05). Furthermore, in both treated groups in comparison to PCOS group, the number of antral follicles significantly increased (P < 0.05). On the other hand, in PCOS group, the number of cystic follicles significantly increased when compared to control group (P < 0.05). Treatment with G. officinalis extract significantly decreased the number of cystic follicles in comparison to rats with PCOS received no therapy (P < 0.05). In addition, evaluating the number of yellow bodies showed a significant decrease in PCOS group compared to control group (P < 0.05). Additionally, Control: healthy control group; PCOS: PCOS group that received normal saline by oral gavage; PG200: PCOS group treated with hydroalcoholic extract (200 mg/kg) of Galega officinalis; PG400: PCOS group treated with hydroalcoholic extract (400 mg/kg) of Galega Officinalis. All data are displayed as mean ± SE. The asterisk + shows significant difference with control group and the symbol of * means the significant difference with PCOS group (P < 0.05). .3000
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Control PCOS PG200 PG400 Serum Insulin Levels (mIU/mL) Groups Control PCOS PG200 PG400 + * * in both treated groups, PG 200 and PG 400, a significant increase in the number of yellow bodies was observed in comparison to the group affected by PCOS (P < 0.05).
Discussion
Our results showed that G. officinalis had the beneficial effects on the levels of FBS. Similar results were found in a study showed that the decrease in FBS is associated with galegine, a guanidine compound exists in the plant (24) . Moreover, Shen et al indicated that G. officinalis has a similar effect to that of metformin because of possessing Bygvandyn composition. Therefore, it would be plausible Control: healthy control group; PCOS: PCOS group that received normal saline by oral gavage; PG200: PCOS group treated with hydroalcoholic extract (200 mg/kg) of Galega officinalis; PG400: PCOS group treated with hydroalcoholic extract (400 mg/kg) of G. officinalis. All data are displayed as mean ± SE. The asterisk + shows significant difference with control group and the symbol of * means the significant difference with PCOS group (P < 0.05). that G. officinalis could be applied for decreasing the blood sugar (30). Uchiyama et al observed that antioxidants may preclude or postpone the cellular malfunction in diabetes through the protection against toxic levels of glucose (31). Insulin resistance followed by compensatory hyperinsulinemia is considered as the most prominent features among complications resulted from PCOS (32) . Insulin resistance has been reported in 25 to 60% of women afflicted with PCOS (33) . It has also been described that G. officinalis is able to decrease hyperinsulinemia (24). Moreover, the serum level of insulin was decreased in the groups treated with G. officinalis compared with PCOS group. Such decrease may stem from the existence of complexes such as resin, glycoside, saponins, and steroids. Therefore, antioxidant existing in those compounds can protect the beta cells of the pancreas from damage caused by oxidative stress (19) . Some flavonoids can modify the insulin-secreting capacity and modulate beta cell apoptosis. It should be noted that the decrease in antioxidant capacity has been shown to have a correlation with insulin resistance (34) .
A number of studies have illustrated that patients with PCOS have higher levels of LH, FSH, and testosterone, while the level of estrogen is lower in patients affected by PCOS (35) . It has been indicated that the serum activity of aromatase is declined in PCOS patients (35) .
The present study showed that PCOS caused a significant increase in the levels of testosterone, LH, as well as FSH, while the levels of aromatase and estrogen significantly decreased compared to control group. Treatment with G. officinalis extract is capable of increasing the serum levels of aromatase and estrogen and decreasing the levels of LH, FSH, and testosterone. Genazzani et al showed that in patients suffered from PCOS, treatment with metformin can reduce the serum levels of estradiol, LH, as well as insulin (36) . On one hand, the reduction in the serum activity of aromatase in PCOS group may be correlated with the decline in serum estrogen level. Christine et al reported that the serum level of estrogen is decreased in PCOS, while the serum levels of LH, FSH, and testosterone are increased in the patients with PCOS (37) . Reducing the hyperinsulinemia, whether it is caused by weight loss or the administration of metformin/troglitazone, results in a reduction of plasma levels of LH. However, some studies showed that a decrease in plasma levels of LH in response to the reduction of insulin may be similar to a phenomenon in which reduced plasma androgen is caused by a reduction in ovarian androgen secretion by insulin (38) .
Cytochrome P450c-17α is amongst the enzymes whose activity is increased in some disorders such as PCOS. Furthermore, cytochrome P450c-17α is the main enzyme in the synthesis of androgens, which is directly incited by insulin in patients who suffer from PCOS. Yet, metformin can lead to decrease in the plasma levels of androgens, LH, and IGF-I by reducing the level of insulin, which, in turn, resulted in the reduction of action of this enzyme (39) . Insulin is able to prevent the secretion of sex hormonebinding globulin (SHBG) by acting on the liver, hence, the circulating androgens would be increased (40) . The incidence of involuntary ovulation can be increased in women with PCOS who take metformin since it can diminish the levels of insulin (41) . Mu et al showed that the decline in the plasma concentration of estrogens by troglitazone in PCOS may be as a result of the reduced aromatization which in turn leads to the reduction of circulating insulin level (42) . Additionally, Maraca et al reported that in women with PCOS, treatment with metformin could decrease the aromatase activity in response to FSH (41) .
In the present study, in PCOS group, there was a significant decrease in the number of follicles, while the number of cystic follicles was significantly increased. These phenomena might originate from hyperandrogenism that leads to the generation of cystic follicles and reduction of the number of normal follicles (39). Manneras et al reported that PCOS increased the number of atretic antral follicles and decreased the number of healthy antral follicles (43) . Moreover, Badawy et al reported that PCOS caused a reduction in the number of healthy follicles in rats with PCOS (44) . The results showed that treatment with G. officinalis could increase the number of follicles and reduce the number of cystic follicles compared to PCOS group. It can stem from the effects of G. officinalis on serum insulin level and insulin resistance, which are possibly pertained to the presence of Bygvanydyn, flavonoid, saponins in G. officinalis. It has been indicated that these compounds can decrease the insulin resistance and prevent the hyperandrogenism (24, 30) . However, the effects of G. officinalis on preventing the generation of cystic follicles in the groups treated with PG 200 and PG 400 may be due to anti-hyperandrogenic properties of this herb.
In conclusion, our result showed that G. officinalis extract has a striking effect on the level of steroid hormones, the serum aromatase activity, and the serum glucose level in rats. Moreover, the hydroalcoholic extract of G. officinalis could decrease the number of cystic follicles and increase the number of normal follicles. The beneficial effects of G. officinalis may be due to the presence of antioxidant and insulin-like agents such as Bygvanydyn, resin, glycoside, and saponins.
